| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a722744e77c81c5f5cf415087e2ee92b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16222 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-03 |
| filingDate |
1997-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a1679d5a462d19fc703c51ca44afa57d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d59dad03259f2e42db6f98a481c3217e |
| publicationDate |
1998-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9815289-A1 |
| titleOfInvention |
Proteins of kaposi's sarcoma associated herpesvirus |
| abstract |
The present invention is directed to isolated nucleic acid molecules encoding proteins of Kaposi's sarcoma associated herpesvirus, including an antigenic receptor protein, a G protein coupled receptor, and a cyclin protein. Expression vectors and host cells comprising the nucleic acid molecules are also provided, as well as methods for increasing or decreasing the expression of the KSHV proteins in host cells. DNA oligomers and antibodies specific for the KSHV proteins are provided, each of which can be used to detect the KSHV proteins in a sample. Isolated KSHV proteins are also provided. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0934333-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6348586-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010093924-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0208294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0934333-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7932066-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8951723-B2 |
| priorityDate |
1996-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |